Clinical Trial Update: Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to Clinical Trials [NA]

View source ↗

Summary

Updates on a National Taiwan University Hospital program developing microbial therapeutics for metabolic dysfunction-associated fatty liver disease, advancing f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease | NA | Status: RECRUITING